Solution Structure and Interaction with Basic and Acidic Fibroblast Growth Factor of a 3-kDa Human Platelet Factor-4 Fragment with Antiangiogenic Activity* 210

Platelet factor-4 is a protein belonging to the family of ELR-negative CXC chemokines which binds to fibroblast growth factor and inhibits its mitogenic activity. Platelet factor-4 also inhibits tumor growth by mechanisms involving antiangiogenesis. Antiangiogenic activity in vitro has also been shown for the 24-residue C-terminal fragment of the protein, which decreases the affinity between basic fibroblast growth factor and its cell-surface receptor. In this study, the preferential conformation of this fragment in solution has been determined and has been found to be composed of two helical subdomains. In addition, we show that the fragment forms a specific 1:1 complex with acidic and basic fibroblast growth factors and that both subdomains are probably required for inhibition of fibroblast growth factor-driven mitogenesis. Finally, we show that the binding of the fragment alters the structure of the fibroblast growth factors, although some of such alterations do not seem related with the inhibition of mitogenic activity. Since this fragment has recently been shown to inhibit fibroblast growth factor-induced angiogenesis in vivo when injected intraperitoneally, these results are relevant for developing new antiangiogenic treatments.

[1]  M. Redondo-Horcajo,et al.  A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF‐2 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  B D Sykes,et al.  Chemical shifts as a tool for structure determination. , 1994, Methods in enzymology.

[3]  W. Stafford,et al.  Physical characterization of myosin light chains. , 1978, Biochemistry.

[4]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[5]  S. Mandriota,et al.  Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. , 1997, Journal of cell science.

[6]  T. F. Kumosinski,et al.  Measurements of protein hydration by various techniques. , 1985, Methods in enzymology.

[7]  G. Giménez-Gallego,et al.  Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities. , 1986, Biochemical and biophysical research communications.

[8]  A. Pineda-Lucena,et al.  1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate. , 1994, Journal of Molecular Biology.

[9]  J. Thornton,et al.  A revised set of potentials for β‐turn formation in proteins , 1994 .

[10]  G. Giménez-Gallego,et al.  Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. , 1991, The Journal of biological chemistry.

[11]  M. Redondo-Horcajo,et al.  1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. , 2000, Biochemistry.

[12]  D. W. Bolen,et al.  Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.

[13]  K. Wüthrich NMR of proteins and nucleic acids , 1988 .

[14]  R. R. Ernst,et al.  Two‐dimensional spectroscopy. Application to nuclear magnetic resonance , 1976 .

[15]  H. Karasuyama,et al.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.

[16]  C. Tanford,et al.  Molecular characterization of proteins in detergent solutions. , 1974, Biochemistry.

[17]  C. Pace Determination and analysis of urea and guanidine hydrochloride denaturation curves. , 1986, Methods in enzymology.

[18]  L Serrano,et al.  Helix stop and start signals in peptides and proteins. The capping box does not necessarily prevent helix elongation. , 1994, Journal of molecular biology.

[19]  G. Gray,et al.  Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. , 1990, Science.

[20]  G. Bodenhausen,et al.  Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy , 1980 .

[21]  P. Wen,et al.  Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth , 1997, Nature Medicine.

[22]  P. Cuevas,et al.  Fibroblast growth factors, proteins with a broad spectrum of biological activities. , 1994, Neurological research.

[23]  D. Rees,et al.  Three-dimensional structures of acidic and basic fibroblast growth factors. , 1993, Science.

[24]  Arthur J. Rowe,et al.  Analytical ultracentrifugation in biochemistry and polymer science , 1992 .

[25]  R. Lozano,et al.  Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas. , 1998, Journal of molecular biology.

[26]  G. Gray,et al.  Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. , 1991, Cancer research.

[27]  D. Mosher,et al.  Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. , 1994, The Journal of clinical investigation.

[28]  François Coulier,et al.  Of Worms and Men: An Evolutionary Perspective on the Fibroblast Growth Factor (FGF) and FGF Receptor Families , 1997, Journal of Molecular Evolution.

[29]  M. Jaye,et al.  Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. , 1992, Biochimica et biophysica acta.

[30]  P K Tsai,et al.  Physical stabilization of acidic fibroblast growth factor by polyanions. , 1993, Archives of biochemistry and biophysics.

[31]  N. Itoh,et al.  Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. , 1999, Biochimica et biophysica acta.

[32]  M. Blaber,et al.  Thermodynamic characterization of mutants of human fibroblast growth factor 1 with an increased physiological half-life. , 2000, Biochemistry.

[33]  K Wüthrich,et al.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. , 1980, Biochemical and biophysical research communications.

[34]  J. Singh,et al.  Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression , 1994, The Journal of cell biology.

[35]  P. Cuevas,et al.  Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during post-ischemic reperfusion. , 1997, Growth factors.

[36]  L Serrano,et al.  The folding of an enzyme. IV. Structure of an intermediate in the refolding of barnase analysed by a protein engineering procedure. , 1992, Journal of molecular biology.

[37]  Y. Nemerson,et al.  Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. , 1993, Biochemistry.

[38]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[39]  A. Pineda-Lucena,et al.  Effect of low pH and heparin on the structure of acidic fibroblast growth factor. , 1994, European journal of biochemistry.

[40]  N. Ferrara Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.

[41]  H. Byers,et al.  Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. , 1990, Journal of the National Cancer Institute.

[42]  László Szilágyi,et al.  Chemical shifts in proteins come of age , 1995 .

[43]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[44]  Y H Chen,et al.  Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. , 1972, Biochemistry.

[45]  K. Wüthrich,et al.  Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.

[46]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[47]  K Wüthrich,et al.  Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. , 1991, Journal of molecular biology.

[48]  A. Bikfalvi,et al.  Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. , 1998, Blood.

[49]  T. Laue,et al.  Modern Analytical Ultracentrifugation , 1994, Emerging Biochemical and Biophysical Techniques.

[50]  D. Rees,et al.  Production and characterization of an analog of acidic fibroblast growth factor with enhanced stability and biological activity. , 1993, Protein engineering.

[51]  R. Heinrikson,et al.  Amino acid sequence of human platelet factor 4. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Pineda-Lucena,et al.  Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog. , 1996, Journal of molecular biology.

[53]  K Wüthrich,et al.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules , 1995, Journal of biomolecular NMR.

[54]  A. Bikfalvi,et al.  Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. , 1999, Blood.

[55]  J. Fiddes,et al.  Human basic fibroblast growth factor: nucleotide sequence and genomic organization. , 1986, The EMBO journal.

[56]  G. Giménez-Gallego,et al.  The complete amino acid sequence of human brain-derived acidic fibroblast growth factor. , 1986, Biochemical and biophysical research communications.

[57]  J. Loscalzo,et al.  The interaction of platelet factor four and glycosaminoglycans. , 1985, Archives of biochemistry and biophysics.

[58]  Eric Oldfield,et al.  1H, 13C and 15N chemical shift referencing in biomolecular NMR , 1995, Journal of biomolecular NMR.

[59]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[60]  A. Halfpenny,et al.  The structure of human acidic fibroblast growth factor and its interaction with heparin. , 1991, Archives of biochemistry and biophysics.

[61]  A. Pineda-Lucena,et al.  X-ray structure of native full-length human fibroblast-growth factor at 0.25-nm resolution. , 1996, European journal of biochemistry.

[62]  Luis Serrano,et al.  The hydrophobic-staple motif and a role for loop-residues in α-helix stability and protein folding , 1995, Nature Structural Biology.

[63]  L. Chen,et al.  Crystal structure of recombinant human platelet factor 4. , 1994, Biochemistry.

[64]  L Serrano,et al.  Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. , 1997, Biopolymers.

[65]  P E Wright,et al.  Use of chemical shifts and coupling constants in nuclear magnetic resonance structural studies on peptides and proteins. , 1994, Methods in enzymology.

[66]  J. Singh,et al.  A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Hodges,et al.  Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide. , 1992, Biochemistry.

[68]  T. Maione,et al.  Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. , 1995, Journal of the National Cancer Institute.

[69]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[70]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[71]  K Wüthrich,et al.  Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances. , 1984, Journal of molecular biology.

[72]  J. Philo An improved function for fitting sedimentation velocity data for low-molecular-weight solutes. , 1997, Biophysical journal.

[73]  F. Blanco,et al.  NMR evidence of a short linear peptide that folds into a .beta.-hairpin in aqueous solution , 1993 .

[74]  P. Gleizes,et al.  Cell Release of Bioactive Fibroblast Growth Factor 2 by Exon 6-encoded Sequence of Vascular Endothelial Growth Factor* , 1997, The Journal of Biological Chemistry.

[75]  K. J. Brown,et al.  Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor. , 1994, Biochemistry.

[76]  R. Bradshaw TIBS—the second decade , 1986 .

[77]  L. Kay,et al.  Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta. , 1989, Biochemistry.

[78]  G. D'alessio,et al.  A method for synthesizing genes and cDNAs by the polymerase chain reaction. , 1993, Analytical biochemistry.

[79]  M. Blaber,et al.  X-ray crystal structure of human acidic fibroblast growth factor. , 1996, Biochemistry.

[80]  R. Lozano,et al.  High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions. , 1992, Gene.